{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:42:43Z","timestamp":1741153363704,"version":"3.38.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shenzhen Science and Technology Program","award":["JCYJ20240813162500001"],"award-info":[{"award-number":["JCYJ20240813162500001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04008-1","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:41:05Z","timestamp":1741066865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Osteopontin promotes keratinocyte proliferation by G0\/G1 cell cycle arrest in psoriasis"],"prefix":"10.1007","volume":"317","author":[{"given":"Siyi","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"1","key":"4008_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Chen Y, Cui L, Shi Y, Guo C (2022) Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis 13(1):81","journal-title":"Cell Death Dis"},{"issue":"4","key":"4008_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman NJ (2020) Management of psoriasis as a systemic disease: what is the evidence? Br J Dermatol 182(4):840\u2013848","journal-title":"Br J Dermatol"},{"issue":"6","key":"4008_CR3","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/1346-8138.15840","volume":"48","author":"F Yamazaki","year":"2021","unstructured":"Yamazaki F (2021) Psoriasis: Comorbidities. J Dermatol 48(6):732\u2013740","journal-title":"J Dermatol"},{"issue":"5","key":"4008_CR4","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/ijms21051690","volume":"21","author":"M Kamata","year":"2020","unstructured":"Kamata M, Tada Y (2020) Efficacy and safety of biologics for psoriasis and psoriatic arthritis and their impact on comorbidities: a literature review. Int J Mol Sci 21(5):1690","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4008_CR5","doi-asserted-by":"publisher","first-page":"adv00030","DOI":"10.2340\/00015555-3384","volume":"100","author":"N Dand","year":"2020","unstructured":"Dand N, Mahil SK, Capon F, Smith CH, Simpson MA, Barker JN (2020) Psoriasis and genetics. Acta Derm Venereol 100(3):adv00030","journal-title":"Acta Derm Venereol"},{"key":"4008_CR6","doi-asserted-by":"publisher","first-page":"155897","DOI":"10.1016\/j.cyto.2022.155897","volume":"156","author":"KL Sachen","year":"2022","unstructured":"Sachen KL, Arnold Greving CN, Towne JE (2022) Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions. Cytokine 156:155897","journal-title":"Cytokine"},{"key":"4008_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/bs.acc.2020.04.004","volume":"100","author":"CC de Alcantara","year":"2021","unstructured":"de Alcantara CC, Reiche EMV, Sim\u00e3o ANC (2021) Cytokines in psoriasis. Adv Clin Chem 100:171\u2013204","journal-title":"Adv Clin Chem"},{"issue":"8","key":"4008_CR8","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.3390\/ijms23084457","volume":"23","author":"T Tashiro","year":"2022","unstructured":"Tashiro T, Sawada Y (2022) Psoriasis and systemic inflammatory disorders. Int J Mol Sci 23(8):4457","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4008_CR9","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.jid.2022.02.016","volume":"142","author":"Z Yu","year":"2022","unstructured":"Yu Z, Yu Q, Xu H, Dai X, Yu Y, Cui L et al (2022) IL-17A promotes psoriasis-associated keratinocyte proliferation through ACT1-dependent activation of YAP-AREG Axis. J Invest Dermatol 142(9):2343\u20132352","journal-title":"J Invest Dermatol"},{"issue":"6","key":"4008_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00418-019-01770-y","volume":"151","author":"J Luukkonen","year":"2019","unstructured":"Luukkonen J, Hilli M, Nakamura M, Ritamo I, Valmu L, Kauppinen K et al (2019) Osteoclasts secrete osteopontin into resorption lacunae during bone resorption. Histochem Cell Biol 151(6):475\u2013487","journal-title":"Histochem Cell Biol"},{"issue":"11","key":"4008_CR11","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.3390\/cancers12113379","volume":"12","author":"HR Moorman","year":"2020","unstructured":"Moorman HR, Poschel D, Klement JD, Lu C, Redd PS, Liu K (2020) Osteopontin: a key regulator of tumor progression and immunomodulation. Cancers 12(11):3379","journal-title":"Cancers"},{"issue":"4","key":"4008_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cac2.12414","volume":"43","author":"JW Eun","year":"2023","unstructured":"Eun JW, Yoon JH, Ahn HR, Kim S, Kim YB, Lim SB et al (2023) Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer Commun (Lond) 43(4):455\u2013479","journal-title":"Cancer Commun (Lond)"},{"key":"4008_CR13","doi-asserted-by":"publisher","first-page":"1014853","DOI":"10.3389\/fendo.2022.1014853","volume":"13","author":"Y Du","year":"2022","unstructured":"Du Y, Mao L, Wang Z, Yan K, Zhang L, Zou J (2022) Osteopontin - The stirring multifunctional regulatory factor in multisystem aging. Front Endocrinol (Lausanne) 13:1014853","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"4008_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/nu16020312","volume":"16","author":"L Wang","year":"2024","unstructured":"Wang L, Niu X (2024) Immunoregulatory roles of osteopontin in diseases. Nutrients 16(2):312","journal-title":"Nutrients"},{"key":"4008_CR15","doi-asserted-by":"publisher","first-page":"953283","DOI":"10.3389\/fonc.2022.953283","volume":"12","author":"Y Tan","year":"2022","unstructured":"Tan Y, Zhao L, Yang YG, Liu W (2022) The role of osteopontin in tumor progression through tumor-associated macrophages. Front Oncol 12:953283","journal-title":"Front Oncol"},{"key":"4008_CR16","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.919159","volume":"26","author":"J Si","year":"2020","unstructured":"Si J, Wang C, Zhang D, Wang B, Zhou Y (2020) Osteopontin in bone metabolism and bone diseases. Med Sci Monit 26:e919159","journal-title":"Med Sci Monit"},{"issue":"13","key":"4008_CR17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147413","volume":"6","author":"L MacDonald","year":"2021","unstructured":"MacDonald L, Alivernini S, Tolusso B, Elmesmari A, Somma D, Perniola S et al (2021) COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight 6(13):e147413","journal-title":"JCI Insight"},{"issue":"6","key":"4008_CR18","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1002\/jnr.24954","volume":"99","author":"SU Vay","year":"2021","unstructured":"Vay SU, Olschewski DN, Petereit H, Lange F, Nazarzadeh N, Gross E et al (2021) Osteopontin regulates the proliferation, migration, and survival of astrocytes depending on their activation phenotype. J Neurosci Res 99(6):2822\u20132843","journal-title":"J Neurosci Res"},{"issue":"1","key":"4008_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12885-016-2396-9","volume":"16","author":"S Saleh","year":"2016","unstructured":"Saleh S, Thompson DE, McConkey J, Murray P, Moorehead RA (2016) Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells. BMC Cancer 16(1):359","journal-title":"BMC Cancer"},{"issue":"3","key":"4008_CR20","doi-asserted-by":"publisher","first-page":"581395","DOI":"10.3389\/pore.2021.581395","volume":"27","author":"T Kiss","year":"2021","unstructured":"Kiss T, J\u00e1mbor K, Koroknai V, Sz\u00e1sz I, B\u00e1rdos H, Mok\u00e1nszki A et al (2021) Silencing osteopontin expression inhibits proliferation, invasion and induce altered protein expression in melanoma cells. Pathol Oncol Res 27(3):581395","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"4008_CR21","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1080\/21691401.2019.1666862","volume":"47","author":"G Wang","year":"2019","unstructured":"Wang G, Chu P, Chen M, Cheng L, Zhao C, Chen S et al (2019) Osteopontin promotes rat hepatocyte proliferation both in vitro and in vivo. Artif Cells Nanomed Biotechnol 47(1):3745\u20133757","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"5","key":"4008_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.bone.2003.11.027","volume":"34","author":"W Huang","year":"2004","unstructured":"Huang W, Carlsen B, Rudkin G, Berry M, Ishida K, Yamaguchi DT et al (2004) Osteopontin is a negative regulator of proliferation and differentiation in MC3T3-E1 pre-osteoblastic cells. Bone 34(5):799\u2013808","journal-title":"Bone"},{"issue":"4","key":"4008_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3390\/jcm10040755","volume":"10","author":"J Bartosi\u0144ska","year":"2021","unstructured":"Bartosi\u0144ska J, Przepi\u00f3rka-Kosi\u0144ska J, Sarecka-Hujar B, Raczkiewicz D, Kowal M, Chyl-Surdacka K et al (2021) Osteopontin serum concentration and metabolic syndrome in male psoriatic patients. J Clin Med 10(4):755","journal-title":"J Clin Med"},{"issue":"3","key":"4008_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4103\/0019-5154.182434","volume":"61","author":"MY Abdel-Mawla","year":"2016","unstructured":"Abdel-Mawla MY, El-Kasheshy KA, Ghonemy S, Al Balat W, Elsayed AA (2016) Role of osteopontin in psoriasis: an immunohistochemical study. Indian J Dermatol 61(3):301\u2013307","journal-title":"Indian J Dermatol"},{"issue":"12","key":"4008_CR25","doi-asserted-by":"publisher","first-page":"1285951","DOI":"10.3389\/fimmu.2023.1285951","volume":"14","author":"S Tang","year":"2024","unstructured":"Tang S, Hu H, Li M, Zhang K, Wu Q, Liu X et al (2024) OPN promotes pro-inflammatory cytokine expression via ERK\/JNK pathway and M1 macrophage polarization in Rosacea. Front Immunol 14(12):1285951","journal-title":"Front Immunol"},{"issue":"4","key":"4008_CR26","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/jcp.30978","volume":"238","author":"H Yin","year":"2023","unstructured":"Yin H, Hu M, Li D (2023) Regulation of epidermal stratification and development by basal keratinocytes. J Cell Physiol 238(4):742\u2013748","journal-title":"J Cell Physiol"},{"issue":"10","key":"4008_CR27","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/j.jid.2017.05.015","volume":"137","author":"L Yang","year":"2017","unstructured":"Yang L, Fan X, Cui T, Dang E, Wang G (2017) Nrf2 Promotes Keratinocyte Proliferation in Psoriasis through Up-Regulation of Keratin 6, Keratin 16, and Keratin 17. J Invest Dermatol 137(10):2168\u20132176","journal-title":"J Invest Dermatol"},{"issue":"19","key":"4008_CR28","doi-asserted-by":"publisher","first-page":"10841","DOI":"10.3390\/ijms221910841","volume":"22","author":"A Orsmond","year":"2021","unstructured":"Orsmond A, Bereza-Malcolm L, Lynch T, March L, Xue M (2021) Skin barrier dysregulation in psoriasis. Int J Mol Sci 22(19):10841","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4008_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/imm.13152","volume":"160","author":"ES Chambers","year":"2020","unstructured":"Chambers ES, Vukmanovic-Stejic M (2020) Skin barrier immunity and aging. Immunology 160(2):116\u2013125","journal-title":"Immunology"},{"issue":"2","key":"4008_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jaad.2008.09.046","volume":"60","author":"YJ Chen","year":"2009","unstructured":"Chen YJ, Shen JL, Wu CY, Chang YT, Chen CM, Lee FY (2009) Elevated plasma osteopontin level is associated with the occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis. J Am Acad Dermatol 60(2):225\u2013230","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"4008_CR31","first-page":"235","volume":"117","author":"SJ Liu","year":"2004","unstructured":"Liu SJ, Hu GF, Liu YJ, Liu SG, Gao H, Zhang CS (2004) Effect of human osteopontin on proliferation, transmigration and expression of MMP-2 and MMP-9 in osteosarcoma cells. Chin Med J (Engl) 117(2):235\u2013240","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"4008_CR32","first-page":"1225","volume":"4","author":"J Zheng","year":"2011","unstructured":"Zheng J, Hou Z, Jiao NL (2011) Effects of osteopontin downregulation on the growth of prostate cancer PC-3 cells. Mol Med Rep 4(6):1225\u20131231","journal-title":"Mol Med Rep"},{"issue":"2","key":"4008_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/sj.jid.5700008","volume":"126","author":"D Raj","year":"2006","unstructured":"Raj D, Brash DE, Grossman D (2006) Keratinocyte apoptosis in epidermal development and disease. J Invest Dermatol 126(2):243\u2013257","journal-title":"J Invest Dermatol"},{"issue":"3","key":"4008_CR34","first-page":"182","volume":"17","author":"M Kastelan","year":"2009","unstructured":"Kastelan M, Prpi\u0107-Massari L, Brajac I (2009) Apoptosis in psoriasis. Acta Dermatovenerol Croat 17(3):182\u2013186","journal-title":"Acta Dermatovenerol Croat"},{"issue":"1","key":"4008_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/1477-7819-12-189","volume":"12","author":"KH Hsu","year":"2014","unstructured":"Hsu KH, Tsai HW, Lin PW, Hsu YS, Lu PJ, Shan YS (2014) Anti-apoptotic effects of osteopontin through the up-regulation of Mcl-1 in gastrointestinal stromal tumors. World J Surg Oncol 12(1):189","journal-title":"World J Surg Oncol"},{"issue":"1","key":"4008_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.surg.2006.02.005","volume":"140","author":"PY Wai","year":"2006","unstructured":"Wai PY, Guo L, Gao C, Mi Z, Guo H, Kuo PC (2006) Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation. Surgery 140(1):132\u2013140","journal-title":"Surgery"},{"issue":"1","key":"4008_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/imr.13081","volume":"311","author":"A Yim","year":"2022","unstructured":"Yim A, Smith C, Brown AM (2022) Osteopontin\/secreted phosphoprotein-1 harnesses glial-, immune-, and neuronal cell ligand-receptor interactions to sense and regulate acute and chronic neuroinflammation. Immunol Rev 311(1):224\u2013233","journal-title":"Immunol Rev"},{"issue":"3","key":"4008_CR38","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.3390\/ijms24032942","volume":"24","author":"ACSDF Bastos","year":"2023","unstructured":"Bastos ACSDF, Gomes AVP, Silva GR, Emerenciano M, Ferreira LB, Gimba ERP (2023) The intracellular and secreted sides of osteopontin and their putative physiopathological roles. Int J Mol Sci 24(3):2942","journal-title":"Int J Mol Sci"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04008-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04008-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04008-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T17:23:38Z","timestamp":1741109018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04008-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4008"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04008-1","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The research was carried out following the ethical standards set out by the Ethics Committee of the Peking University Shenzhen Hospital (2,022,022). Approval for this study was granted on 23 March 2022 and was carried out under ethical standards defined in the Declaration of Helsinki. All participants including patients and healthy volunteers provided informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"519"}}